ArticleFrontiers in genetics2022

TROY Modulates Cancer Stem-Like Cell Properties and Gefitinib Resistance Through EMT Signaling in Non-Small Cell Lung Cancer.

Linying Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.